• 
• 
• 
• 
• 

OrbiMed Israel has signed a definitive agreement to invest $7.15 million in RDD PHARMA, an Israeli company developing drugs for ano-rectal diseases. This is the first major round of financing for the company, which was founded in 2009 by Dr. Nir Bara...

» Read more